Johnson & Johnson's Single Dose Covid-19 Vaccine Approved For Emergency Use In India

Team Latestly Aug 09, 2021 01:01 PM IST

India on August 7, granted Johnson & Johnson's (J&J) single-dose vaccine against Covid-19, approval for emergency use in the country. The American pharmaceuticals company had applied to the Central Drug Standard Control Organisation (CDSCO) on August 5 seeking approval. With approval for J&J vaccine, the central government has now granted EUA to a total of five Covid-19 vaccines. India has so far administered the Covishield, Covaxin & Sputnik V vaccines. India has so far administered the Covishield, Covaxin & Sputnik V vaccines. Cipla, Mumbai-based pharmaceuticals company has also been granted approval to import the Moderna vaccine, which has shown 95 per cent efficacy against the disease. Watch the video to know more.

(The above story first appeared on LatestLY on Aug 09, 2021 01:01 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).

Tags

Cipla COVAXIN COVID 19 COVID-19 Vaccines Covishield Eua J&J Vaccine J&J Vaccine Approved Moderna Vaccine Mumbai Sputnik V vaccines

Follow us on News

You Might Also Like

Christmas Carnivals in Mumbai City

ISL 2024–25 Points Table Updated Live: Kerala Blasters Move in Top-10 With Win Over Mohammedan SC, Mohun Bagan Super Giant Remains At Top

Mumbai Shocker: 2 Brothers Kill Ola Cab Driver With Chopper and Knife in Shivaji Nagar After His Vehicle Grazes Scooter and Injures Their Mother, Accused Arrested

Buy Team India New ODI Jersey Online: Here Is How You Can Purchase Indian Cricket Team ODI Kit by Adidas, Check MRP and Other Details

Categories